Keryx Biopharmaceuticals, Inc et al v. Mylan Pharmaceuticals Inc.
| Chen Hsing Hsu, Panion & BF Biotech, Inc. and Keryx Biopharmaceuticals, Inc |
| Mylan Pharmaceuticals Inc. |
| 1:2019cv00040 |
| March 15, 2019 |
| US District Court for the Northern District of West Virginia |
| Thomas S Kleeh |
| Patent - Abbreviated New Drug Applications (ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 15, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 4 REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. (jmm) |
| Filing 3 Corporate Disclosure Statement by Panion & BF Biotech, Inc. (jmm) |
| Filing 2 Corporate Disclosure Statement by Keryx Biopharmaceuticals, Inc identifying Corporate Parent Akebia Therapeutics, Inc. for Keryx Biopharmaceuticals, Inc.(jmm) |
| Filing 1 COMPLAINT against Mylan Pharmaceuticals Inc., filed by Keryx Biopharmaceuticals, Inc, Chen Hsing Hsu, Panion & BF Biotech, Inc. (Attachments: #1 Exhibit A Patent No. 706, #2 Exhibit B Patent No. 851, #3 Exhibit C Patent No. 423, #4 Exhibit D Patent No. 298, #5 Exhibit E Patent No. 642, #6 Exhibit F Patent No. 896, #7 Exhibit G Patent No. 257, #8 Exhibit H Patent No. 258, #9 Exhibit I Patent No. 976, #10 Exhibit J. Patent No. 349, #11 Exhibit K. Patent No. 316, #12 Exhibit L. Patent No. 133, #13 Exhibit M. Patent No. 191, #14 Exhibit N Patent No. 416, #15 Civil Cover Sheet)Filing Fee $400. Receipt #0424-2777229.(jmm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
